BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27665585)

  • 21. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for lymphedema after breast cancer treatment.
    Norman SA; Localio AR; Kallan MJ; Weber AL; Torpey HA; Potashnik SL; Miller LT; Fox KR; DeMichele A; Solin LJ
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2734-46. PubMed ID: 20978176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Lymphedema Surveillance Program for Breast Cancer Patients Reveals the Promise of Surgical Prevention.
    Hahamoff M; Gupta N; Munoz D; Lee BT; Clevenger P; Shaw C; Spiguel L; Singhal D
    J Surg Res; 2019 Dec; 244():604-611. PubMed ID: 29397949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sentinel node biopsy and quality of life measures in a Chinese population.
    Chen JJ; Huang XY; Liu ZB; Chen TW; Cheng JY; Yang WT; Xu WP; Shao ZM; Shen ZZ; Wu J
    Eur J Surg Oncol; 2009 Sep; 35(9):921-7. PubMed ID: 19233602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
    Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
    Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results.
    Cowher MS; Grobmyer SR; Lyons J; O'Rourke C; Baynes D; Crowe JP
    J Am Coll Surg; 2014 Apr; 218(4):819-24. PubMed ID: 24655877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-reported outcomes and objective assessments with arm measurement and bioimpedance analysis for lymphedema among breast cancer survivors.
    Terada M; Yoshimura A; Sawaki M; Hattori M; Naomi G; Kotani H; Adachi Y; Iwase M; Kataoka A; Sugino K; Mori M; Horisawa N; Ozaki Y; Iwata H
    Breast Cancer Res Treat; 2020 Jan; 179(1):91-100. PubMed ID: 31535321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphedema Incidence After Axillary Lymph Node Dissection: Quantifying the Impact of Radiation and the Lymphatic Microsurgical Preventive Healing Approach.
    Johnson AR; Kimball S; Epstein S; Recht A; Lin SJ; Lee BT; James TA; Singhal D
    Ann Plast Surg; 2019 Apr; 82(4S Suppl 3):S234-S241. PubMed ID: 30855393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The changing role of axillary treatment in breast cancer: Who will remain at risk for developing arm morbidity in the future?
    Lopez Penha TR; van Roozendaal LM; Smidt ML; Boersma LJ; von Meyenfeldt MF; Voogd AC; Heuts EM
    Breast; 2015 Oct; 24(5):543-7. PubMed ID: 26051795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
    Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection.
    Golshan M; Martin WJ; Dowlatshahi K
    Am Surg; 2003 Mar; 69(3):209-11; discussion 212. PubMed ID: 12678476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up.
    Ribeiro Pereira ACP; Koifman RJ; Bergmann A
    Breast; 2017 Dec; 36():67-73. PubMed ID: 28992556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation?
    Hayes SB; Freedman GM; Li T; Anderson PR; Ross E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1449-55. PubMed ID: 19028274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
    Fu Y; Chung D; Cao MA; Apple S; Chang H
    Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of breast cancer-related lymphedema: is it dependent on the patient, the tumor or the treating physicians?
    Morcos B; Ahmad FA; Anabtawi I; Sba' AM; Shabani H; Yaseen R
    Surg Today; 2014 Jan; 44(1):100-6. PubMed ID: 23377553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures.
    Sagen A; Kaaresen R; Sandvik L; Thune I; Risberg MA
    Arch Phys Med Rehabil; 2014 May; 95(5):875-81. PubMed ID: 24389401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
    Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
    Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility and Clinical Utility of Prediction Models for Breast Cancer-Related Lymphedema Incorporating Racial Differences in Disease Incidence.
    Rochlin DH; Barrio AV; McLaughlin S; Van Zee KJ; Woods JF; Dayan JH; Coriddi MR; McGrath LA; Bloomfield EA; Boe L; Mehrara BJ
    JAMA Surg; 2023 Sep; 158(9):954-964. PubMed ID: 37436762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis.
    Shaitelman SF; Chiang YJ; Griffin KD; DeSnyder SM; Smith BD; Schaverien MV; Woodward WA; Cormier JN
    Breast Cancer Res Treat; 2017 Apr; 162(2):201-215. PubMed ID: 28012086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study.
    Kuroda K; Yamamoto Y; Yanagisawa M; Kawata A; Akiba N; Suzuki K; Naritaka K
    BMC Womens Health; 2017 Jul; 17(1):50. PubMed ID: 28743274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.